These Companies Are Researching The Future Of CBD Oil
CBD oil stock is rising, both metaphorically, in the eyes of the public-at-large, and literally, as the industry readies itself to near the $2 billion mark sometime in the next decade. As such, more research continues to be dedicated to learning about and understanding the power and benefits of cannabidiol. In fact, recently cannabis news website PotNetwork took a look at some of the top companies in the CBD industry, to see where CBD oil research is now, and where it is heading in the future.
It’s an impressive list, not only because of who’s on it but because of the breakthroughs that appear to be coming down the pipeline in the near future. CBD oil research seems to benefit from the legalization of cannabis as well, according to PotNetwork, as more and more begin to realize the health benefits of each.
CBD Oil In The Fight Against Multiple Sclerosis
Leading the list was GW Pharmaceuticals, the company that recently made headlines with its breakthrough drug Epidiolex. That drug, which is derived from CBD and is designed to fight rare forms of childhood epilepsy, recently became the first drug derived from cannabis to be approved by the U.S. Food and Drug Administration (FDA).
GW Pharmaceuticals is back at it again, this time looking to use CBD oil to fight Multiple Sclerosis (MS). Their new drug, Sativex, attempts to reduce inflammation caused by the disease while protecting nerves from long-term damage.
“Because spastic symptoms are unpredictable, GW Pharmaceuticals created Sativex as an oral spray for a quick and easy application,” notes the article in PotNetwork. “Patients can use Sativex when symptoms hit to reduce discomfort or use the spray every day to slow symptoms.” Currently, the drug is available in 29 states but is still waiting for approval in the U.S.
ALS Has A New Enemy In CBD Oil
Cannabis company CannTrust Holdings recently partnered with Australia’s Gold Coast University Hospital to see if CBD Oil can help in the fight against Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. ALS affects a person’s spinal cord, causing degeneration and inflammation, with no known cure for the disease currently available.
“This study will help advance our understanding of the potential effects of CannTrust's standardized CBD oil capsules on ALS/MND, both as a disease-modifying agent and as a symptomatic treatment and will become the basis for conducting future cannabinoid and ALS clinical trials,” said Dr. Sabet, a senior specialist with the hospital about the study, according to PotNetwork.
CBD Oil vs. Fentanyl
As the opioid epidemic ravages the United States, along with many other countries, researchers from all over continue to look for ways to help those suffering from substance use disorders. Tetra Bio-Pharma Inc. is conducting a study comparing the use of CBD oil to fentanyl to see which one can better assist with pain relief.
The company partnered up with Santѐ Cannabis, an independent cannabis research organization in Quebec and focused their efforts on those with chronic pain issues. They are hoping to provide patients with a natural alternative to opioid pain relievers, according to PotNetwork.
“The development of a THC-based alternative would help provide a safer option to these patients and help prevent overdosing on fentanyl,” said Dr. Antonio Vigano, in a statement about the trials.
The Future of CBD Oil
While it’s still too early to tell what the future holds for some of these studies, considering the history of CBD oil research across the globe, it’s already a giant leap forward from where patients once stood. As public perception changes and industry opens up to the idea of CBD oil as both a potential medication and a moneymaker for stockholders, the chances are likely that more and more research will be done that looks into the benefits of CBD oil.